TELESTA THERAPEUTICS INC T.TST

Buyout Numbers

[prospector001]

Hi all. I am a new poster to this board but have watched the stock for quite some time. The question I would pose to some of the longer-term investors is, considering the 40m+ cash in the bank and the 137m deal with Ipsen, what would a reasonable offer look like for the shares of Telesta? 

Any offer would have to be approved by a majority of the shareholders so I would think it would have to be reasonable. 

At current price levels this stock seems to be such a no-brainer - am I missing something?


GLTA

[faraj69]

The $137 m deal with Ipsen is contingent to getting MCNA FDA approved in US. So Ipsen is definitely looking to save that money and get it approved themselves. In my opinion, considering the company is worth $1/share plus you have big investors who invested at 40 c or more, a reasonable offer would be 50-80 cents a share but others have a smaller window, 15-40 cents. Either way, an easy double

[blartar]

my understanding of the Ipsen deal, is they paid 10 ml up front and the rest after FDA approval. which never happened. so they don't give a damn about a lousy 10 ml loss.  JMHO

[Whatamidoing1]

Well my understanding is "Telesta retains full and sole ownership of MCNA rights in the US and Japan and will be responsible for the commercial launch of MCNA in the United States while Ipsen will initiate discussions with regulatory authorities to identify the regulatory path and potential requirements for the product in Europe and other key licensed territories. " so the ipsen deal is

[account15]

Blartar- not fda but European health agency. Fda would have been nice add on to quick approval. Hopefully Ipsen has good connections.  Also please do not call people who thrown in money at last financing as "....", read up on how quickly they rotate their whole portfolio. Whatever decision was to come from fda re Mcna, they would be gone by now. Quick in/out.  Hopefully very

[faraj69]

True but that contract where it states Ipsen will pay Telesta $137 m if it gets FDA approved is an asset. If Company X buys Telesta and Company X gets MCNA FDA approved, Company X would be entitled to that $137 m. Ipsen is not worried about 10 m, they want their share of the North American market. Why wouldn't Ipsen buyout Telesta a Canadian bio company - where it's cheaper to get things

[peasoupfog]

This post has been removed in accordance with Community Policy